Surgical treatment of central retinal vein occlusion
نویسندگان
چکیده
منابع مشابه
Sulfur Mustard Exposure and Non-Ischemic Central Retinal Vein Occlusion
A 41-year-old man was referred with a complaint of visual loss in his left eye and his best corrected visual acuity was 20/80. Slit lamp examination showed arborizing conjunctival vessels and dry eye. Fundus examination and fluorescein angiography revealed a non-ischemic central retinal vein occlusion. Cardiovascular, rheumatologic, and hematologic work up showed no abnormal findings. An ascert...
متن کاملBranch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
A 59-year-old woman with history of noninsulin dependent diabetes mellitus and systemic hypertension presented with decreased vision in her left eye since 2 months ago. Bestcorrected visual acuity (BCVA) was 20/20 and 20/400 in the right and left eyes respectively. Relative afferent pupillary defect was negative. Anterior segment examination was unremarkable except for mild posterior subcapsula...
متن کاملRetinal Pathology after Central Retinal Vein Occlusion.
OCCLUSION of the central retinal vein causes incomplete haemorrhagic infarction of the inner layers of the retina. Haemorrhagic infarction describes a situation in which the venous backflow of an area of tissue is interrupted. As a result the flow of blood has to stop; ischaemia and resulting increase of vascular permeability lead to retinal oedema and extensive haemorrhages. The central retina...
متن کاملInvestigating the frequency characteristics of the electroretinogram signal in patients with central retinal vein occlusion
Background: Central retinal vein occlusion (CRVO) is the second most common retinal vascular disorder after diabetic retinopathy. In this study, we tried to examine the potentials of time-frequency methods for differentiating the eyes with CRVO. Materials and methods: Twenty patients with unilateral CRVO were included in this study. Their contralateral normal eyes were considered as the control...
متن کاملAnti-VEGF in treatment of central retinal vein occlusion.
Macular edema along with macular ischemia is responsible for decreased visual acuity in central retinal vein occlusion. Bevacizumab (Avastin, Genentech) blocks vascular endothelial growth factor (VEGF) induced hyperpermeability of blood vessels. In this prospective case series we investigated the efficacy of anti-VEGF treatment in reduction of central retinal thickness (CRT) and improvement in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Ophthalmologica
سال: 2008
ISSN: 1755-375X
DOI: 10.1111/j.1755-3768.2007.01144.x